Medical - Healthcare Information Services
Compare Stocks
4 / 10Stock Comparison
TDOC vs UNH vs CVS vs AMWL
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
Medical - Healthcare Plans
Medical - Healthcare Information Services
TDOC vs UNH vs CVS vs AMWL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Information Services |
| Market Cap | $1.26B | $335.60B | $111.40B | $129M |
| Revenue (TTM) | $2.51B | $449.71B | $407.90B | $182M |
| Net Income (TTM) | $-171M | $12.04B | $2.93B | $-88M |
| Gross Margin | 65.6% | 18.8% | 13.9% | 38.7% |
| Operating Margin | -7.6% | 4.2% | 1.5% | -50.6% |
| Forward P/E | — | 20.2x | 12.2x | — |
| Total Debt | $1.04B | $78.39B | $93.59B | $5M |
| Cash & Equiv. | $781M | $24.36B | $8.51B | $182M |
TDOC vs UNH vs CVS vs AMWL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 20 | May 26 | Return |
|---|---|---|---|
| Teladoc Health, Inc. (TDOC) | 100 | 3.2 | -96.8% |
| UnitedHealth Group … (UNH) | 100 | 118.6 | +18.6% |
| CVS Health Corporat… (CVS) | 100 | 149.5 | +49.5% |
| American Well Corpo… (AMWL) | 100 | 1.3 | -98.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TDOC vs UNH vs CVS vs AMWL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TDOC plays a supporting role in this comparison — it may shine differently against other peers.
UNH carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 11.8%, EPS growth -14.7%, 3Y rev CAGR 11.4%
- 220.6% 10Y total return vs CVS's 3.5%
- 11.8% revenue growth vs AMWL's -2.0%
- 2.7% margin vs AMWL's -48.2%
CVS is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 0 yrs, beta 0.05, yield 3.1%
- Beta 0.05, yield 3.1%, current ratio 0.84x
- Better valuation composite
- Beta 0.05 vs TDOC's 1.91
AMWL is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 1.47, Low D/E 1.8%, current ratio 3.37x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.8% revenue growth vs AMWL's -2.0% | |
| Value | Better valuation composite | |
| Quality / Margins | 2.7% margin vs AMWL's -48.2% | |
| Stability / Safety | Beta 0.05 vs TDOC's 1.91 | |
| Dividends | 2.4% yield, 25-year raise streak, vs CVS's 3.1%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +34.7% vs UNH's -3.2% | |
| Efficiency (ROA) | 3.9% ROA vs AMWL's -25.1%, ROIC 9.2% vs -95.1% |
TDOC vs UNH vs CVS vs AMWL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TDOC vs UNH vs CVS vs AMWL — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CVS leads in 3 of 6 categories
UNH leads 1 • TDOC leads 0 • AMWL leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — TDOC and UNH and CVS each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 2464.3x AMWL's $182M. UNH is the more profitable business, keeping 2.7% of every revenue dollar as net income compared to AMWL's -48.2%. On growth, CVS holds the edge at +6.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.5B | $449.7B | $407.9B | $182M |
| EBITDAEarnings before interest/tax | $42M | $23.2B | $10.5B | -$59M |
| Net IncomeAfter-tax profit | -$171M | $12.0B | $2.9B | -$88M |
| Free Cash FlowCash after capex | $251M | $19.7B | $7.4B | -$42M |
| Gross MarginGross profit ÷ Revenue | +65.6% | +18.8% | +13.9% | +38.7% |
| Operating MarginEBIT ÷ Revenue | -7.6% | +4.2% | +1.5% | -50.6% |
| Net MarginNet income ÷ Revenue | -6.8% | +2.7% | +0.7% | -48.2% |
| FCF MarginFCF ÷ Revenue | +10.0% | +4.4% | +1.8% | -22.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.5% | +2.0% | +6.2% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +32.1% | +0.7% | +63.1% | +44.5% |
Valuation Metrics
CVS leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 27.9x trailing earnings, UNH trades at a 56% valuation discount to CVS's 62.8x P/E. On an enterprise value basis, CVS's 13.1x EV/EBITDA is more attractive than UNH's 16.7x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.3B | $335.6B | $111.4B | $129M |
| Enterprise ValueMkt cap + debt − cash | $1.5B | $389.6B | $196.5B | -$48M |
| Trailing P/EPrice ÷ TTM EPS | -6.11x | 27.95x | 62.81x | -1.30x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.19x | 12.19x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 15.13x | 16.70x | 13.11x | — |
| Price / SalesMarket cap ÷ Revenue | 0.50x | 0.75x | 0.28x | 0.52x |
| Price / BookPrice ÷ Book value/share | 0.89x | 3.31x | 1.47x | 0.50x |
| Price / FCFMarket cap ÷ FCF | 4.40x | 20.88x | 14.27x | — |
Profitability & Efficiency
UNH leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-33 for AMWL. AMWL carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to CVS's 1.24x. On the Piotroski fundamental quality scale (0–9), TDOC scores 6/9 vs CVS's 5/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -12.4% | +11.5% | +3.9% | -33.5% |
| ROA (TTM)Return on assets | -5.9% | +3.9% | +1.1% | -25.1% |
| ROICReturn on invested capital | -11.5% | +9.2% | +5.0% | -95.1% |
| ROCEReturn on capital employed | -10.0% | +9.7% | +6.1% | -36.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.75x | 0.77x | 1.24x | 0.02x |
| Net DebtTotal debt minus cash | $259M | $54.0B | $85.1B | -$178M |
| Cash & Equiv.Liquid assets | $781M | $24.4B | $8.5B | $182M |
| Total DebtShort + long-term debt | $1.0B | $78.4B | $93.6B | $5M |
| Interest CoverageEBIT ÷ Interest expense | -8.76x | 4.71x | 2.11x | -239.18x |
Total Returns (Dividends Reinvested)
CVS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CVS five years ago would be worth $11,700 today (with dividends reinvested), compared to $278 for AMWL. Over the past 12 months, CVS leads with a +34.7% total return vs UNH's -3.2%. The 3-year compound annual growth rate (CAGR) favors CVS at 11.0% vs AMWL's -42.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -1.3% | +10.6% | +10.6% | +59.8% |
| 1-Year ReturnPast 12 months | +1.5% | -3.2% | +34.7% | +14.3% |
| 3-Year ReturnCumulative with dividends | -73.3% | -19.9% | +36.6% | -80.7% |
| 5-Year ReturnCumulative with dividends | -95.4% | -2.6% | +17.0% | -97.2% |
| 10-Year ReturnCumulative with dividends | -41.1% | +220.6% | +3.5% | -98.3% |
| CAGR (3Y)Annualised 3-year return | -35.6% | -7.1% | +11.0% | -42.2% |
Risk & Volatility
CVS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CVS is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than TDOC's 1.91 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVS currently trades 98.5% from its 52-week high vs TDOC's 71.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.91x | 0.59x | 0.05x | 1.47x |
| 52-Week HighHighest price in past year | $9.77 | $395.52 | $88.63 | $9.15 |
| 52-Week LowLowest price in past year | $4.40 | $234.60 | $58.35 | $3.71 |
| % of 52W HighCurrent price vs 52-week peak | +71.2% | +93.5% | +98.5% | +84.7% |
| RSI (14)Momentum oscillator 0–100 | 74.1 | 75.9 | 69.3 | 67.1 |
| Avg Volume (50D)Average daily shares traded | 5.5M | 7.9M | 7.4M | 59K |
Analyst Outlook
Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: TDOC as "Hold", UNH as "Buy", CVS as "Buy". Consensus price targets imply 9.0% upside for CVS (target: $95) vs 4.2% for UNH (target: $385). For income investors, CVS offers the higher dividend yield at 3.06% vs UNH's 2.35%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | — |
| Price TargetConsensus 12-month target | $7.58 | $385.43 | $95.20 | — |
| # AnalystsCovering analysts | 42 | 52 | 41 | — |
| Dividend YieldAnnual dividend ÷ price | — | +2.4% | +3.1% | — |
| Dividend StreakConsecutive years of raises | — | 25 | 0 | — |
| Dividend / ShareAnnual DPS | — | $8.70 | $2.67 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.7% | 0.0% | +0.0% |
CVS leads in 3 of 6 categories (Valuation Metrics, Total Returns). UNH leads in 1 (Profitability & Efficiency). 2 tied.
TDOC vs UNH vs CVS vs AMWL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TDOC or UNH or CVS or AMWL a better buy right now?
For growth investors, UnitedHealth Group Incorporated (UNH) is the stronger pick with 11.
8% revenue growth year-over-year, versus -2. 0% for American Well Corporation (AMWL). UnitedHealth Group Incorporated (UNH) offers the better valuation at 27. 9x trailing P/E (20. 2x forward), making it the more compelling value choice. Analysts rate UnitedHealth Group Incorporated (UNH) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TDOC or UNH or CVS or AMWL?
On trailing P/E, UnitedHealth Group Incorporated (UNH) is the cheapest at 27.
9x versus CVS Health Corporation at 62. 8x. On forward P/E, CVS Health Corporation is actually cheaper at 12. 2x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — TDOC or UNH or CVS or AMWL?
Over the past 5 years, CVS Health Corporation (CVS) delivered a total return of +17.
0%, compared to -97. 2% for American Well Corporation (AMWL). Over 10 years, the gap is even starker: UNH returned +220. 6% versus AMWL's -98. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TDOC or UNH or CVS or AMWL?
By beta (market sensitivity over 5 years), CVS Health Corporation (CVS) is the lower-risk stock at 0.
05β versus Teladoc Health, Inc. 's 1. 91β — meaning TDOC is approximately 3679% more volatile than CVS relative to the S&P 500. On balance sheet safety, American Well Corporation (AMWL) carries a lower debt/equity ratio of 2% versus 124% for CVS Health Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — TDOC or UNH or CVS or AMWL?
By revenue growth (latest reported year), UnitedHealth Group Incorporated (UNH) is pulling ahead at 11.
8% versus -2. 0% for American Well Corporation (AMWL). On earnings-per-share growth, the picture is similar: Teladoc Health, Inc. grew EPS 80. 6% year-over-year, compared to -62. 0% for CVS Health Corporation. Over a 3-year CAGR, UNH leads at 11. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TDOC or UNH or CVS or AMWL?
UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.
7% net margin versus -38. 4% for American Well Corporation — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -42. 2% for AMWL. At the gross margin level — before operating expenses — TDOC leads at 69. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TDOC or UNH or CVS or AMWL more undervalued right now?
On forward earnings alone, CVS Health Corporation (CVS) trades at 12.
2x forward P/E versus 20. 2x for UnitedHealth Group Incorporated — 8. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CVS: 9. 0% to $95. 20.
08Which pays a better dividend — TDOC or UNH or CVS or AMWL?
In this comparison, CVS (3.
1% yield), UNH (2. 4% yield) pay a dividend. TDOC, AMWL do not pay a meaningful dividend and should not be held primarily for income.
09Is TDOC or UNH or CVS or AMWL better for a retirement portfolio?
For long-horizon retirement investors, CVS Health Corporation (CVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
05), 3. 1% yield). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 91 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CVS: +3. 5%, TDOC: -41. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TDOC and UNH and CVS and AMWL?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: TDOC is a small-cap quality compounder stock; UNH is a large-cap quality compounder stock; CVS is a mid-cap income-oriented stock; AMWL is a small-cap quality compounder stock. UNH, CVS pay a dividend while TDOC, AMWL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.